Skip to main content
Erschienen in:

05.08.2023 | Case Report

Complete investigations (autopsy, toxicology, and histology) in a death due to apixaban overdose

verfasst von: Pascal Kintz, Charlotte Allain, Laetitia Oertel, Emilie Feisthauer, Alice Ameline, Jean-Sébastien Raul

Erschienen in: International Journal of Legal Medicine | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

The dead body of a 54-year-old man was found at home by his partner. He was off work due to depression. A letter with suicidal intention was present on the scene. He was known to be a heavy drinker, and near the body, an empty bottle of whisky was found. In addition, 2 empty blisters of Eliquis (apixaban) 5 mg, corresponding to 40 tablets, were identified. Apixaban is an oral anticoagulant, acting as a factor Xa inhibitor. Autopsy findings were mostly unremarkable, except numerous bruises and some superficial self-inflected wounds. Histology showed hematomas of calyces and renal pelvis and in the liver, several areas of perivenular haemorrhagic necrosis. Others organs were congestive. Femoral venous blood alcohol was 0.11 g/L. In femoral venous blood, a toxic concentration of apixaban was measured at 1184 ng/mL using LC-MS/MS. Other drugs found at therapeutic concentrations included diazepam (99 ng/mL), nordiazepam (171 ng/mL), flecainide (447 ng/mL), and mianserine (65 ng/mL). Using liquid chromatography coupled to high-resolution mass spectrometry, 2 metabolites were identified, O-desmethyl-apixaban (61.8% of the apixaban response) and hydroxyl-apixaban (4.5% of the apixaban response). Long-term therapy was confirmed by a concentration of 10390 pg/mg in pubic hair.
Literatur
1.
Zurück zum Zitat Campbell CL (2006) New treatment options for acute coronary syndromes. AM J Manag Care 12(16 Suppl):S435–S443PubMed Campbell CL (2006) New treatment options for acute coronary syndromes. AM J Manag Care 12(16 Suppl):S435–S443PubMed
2.
Zurück zum Zitat Frazer A, Rowland J, Mudge A, Barras M, Martin J, Donovan P (2019) Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. Eur J Clin Pharmacol 75:1645–1657CrossRefPubMed Frazer A, Rowland J, Mudge A, Barras M, Martin J, Donovan P (2019) Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. Eur J Clin Pharmacol 75:1645–1657CrossRefPubMed
4.
Zurück zum Zitat Kubitza D, Haas S (2006) Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases. Expert Opin Investig Drugs 15:843–855CrossRefPubMed Kubitza D, Haas S (2006) Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases. Expert Opin Investig Drugs 15:843–855CrossRefPubMed
6.
Zurück zum Zitat Frost C, Nepal S, Wang J, Schuster A, Byon W, Boyd RA, Yu Z, Shenker A, Barett YC, Mosqueda-Garcia LCF (2013) Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects. Br J Clin Pharmacol 76:776–786CrossRefPubMedPubMedCentral Frost C, Nepal S, Wang J, Schuster A, Byon W, Boyd RA, Yu Z, Shenker A, Barett YC, Mosqueda-Garcia LCF (2013) Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects. Br J Clin Pharmacol 76:776–786CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ilicki J, Höjer J, Djärv T (2018) Massive apixaban overdose – a comparison of three cases. Am J Emerg Med 36:891–893CrossRefPubMed Ilicki J, Höjer J, Djärv T (2018) Massive apixaban overdose – a comparison of three cases. Am J Emerg Med 36:891–893CrossRefPubMed
9.
Zurück zum Zitat Franck B, Dulaurent S, El Balkhi S, Monchaud C, Picard N, Couderc S, Marquet P, Saint-Marcoux F, Woillard JB (2019) Self-poisoning with 60 tablets of apixaban, a pharmacokinetics case report. Br J Clin Pharmacol 85:270–272CrossRefPubMed Franck B, Dulaurent S, El Balkhi S, Monchaud C, Picard N, Couderc S, Marquet P, Saint-Marcoux F, Woillard JB (2019) Self-poisoning with 60 tablets of apixaban, a pharmacokinetics case report. Br J Clin Pharmacol 85:270–272CrossRefPubMed
10.
Zurück zum Zitat Leikin SM, Patel H, Welker KL, Leikin JB (2017) The X factor: lack of bleeding after an acute apixaban overdose. Am J Emerg Med 35:801e5–801e6CrossRef Leikin SM, Patel H, Welker KL, Leikin JB (2017) The X factor: lack of bleeding after an acute apixaban overdose. Am J Emerg Med 35:801e5–801e6CrossRef
11.
Zurück zum Zitat Delrue M, Chevillard L, Stéphanian A, Dragoni A, Camoin-Jau L, Voicu S, Malissin I, Deye N, Gainnier M, Siguret V, Mégarbane B (2022) Case series of massive direct oral anticoagulant ingestion – treatment and pharmacokinetics data. Eur J Clin Invest 52:e13746. https://doi.org/10.1111/eci.13746CrossRefPubMed Delrue M, Chevillard L, Stéphanian A, Dragoni A, Camoin-Jau L, Voicu S, Malissin I, Deye N, Gainnier M, Siguret V, Mégarbane B (2022) Case series of massive direct oral anticoagulant ingestion – treatment and pharmacokinetics data. Eur J Clin Invest 52:e13746. https://​doi.​org/​10.​1111/​eci.​13746CrossRefPubMed
12.
Zurück zum Zitat Brückner L, Beyer-Westendorf J, Tiebel O, Pietsch J (2022) Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MS. J Throm Thrombolysis 53:777–787CrossRef Brückner L, Beyer-Westendorf J, Tiebel O, Pietsch J (2022) Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MS. J Throm Thrombolysis 53:777–787CrossRef
13.
Zurück zum Zitat Barton J, Wong A, Graudins A (2016) Anti-Xa activity in apixaban overdose: a case report. Clin Toxicol 54:871–873CrossRef Barton J, Wong A, Graudins A (2016) Anti-Xa activity in apixaban overdose: a case report. Clin Toxicol 54:871–873CrossRef
14.
Zurück zum Zitat Launay M, Nasser Y, Maubert I, Chaux AC, Delavenne X (2020) accidental apixaban intoxication in a 23-month old child: a case report. BMC Pediatr 20:546CrossRefPubMedPubMedCentral Launay M, Nasser Y, Maubert I, Chaux AC, Delavenne X (2020) accidental apixaban intoxication in a 23-month old child: a case report. BMC Pediatr 20:546CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Levine M, Beuhler MC, Pizon A, Cantrel FL, Spyres MB, LoVecchio F, Skolnik AB, Brooks DE (2018) Assessing bleeding risk in patients with intentional overdoses of novel antiplatelet and anticoagulation medications. Ann Emerg Med 71:273–278CrossRefPubMed Levine M, Beuhler MC, Pizon A, Cantrel FL, Spyres MB, LoVecchio F, Skolnik AB, Brooks DE (2018) Assessing bleeding risk in patients with intentional overdoses of novel antiplatelet and anticoagulation medications. Ann Emerg Med 71:273–278CrossRefPubMed
18.
Zurück zum Zitat Kintz P, Gheddar L, Raul JS (2021) Simultaneous testing for anabolic steroids in human hair specimens collected from various anatomic locations has several advantages when compared with the standard head hair analysis. Drug Test Anal 13:1445–1451CrossRefPubMed Kintz P, Gheddar L, Raul JS (2021) Simultaneous testing for anabolic steroids in human hair specimens collected from various anatomic locations has several advantages when compared with the standard head hair analysis. Drug Test Anal 13:1445–1451CrossRefPubMed
19.
Zurück zum Zitat Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D (2009) Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos 37:74–81CrossRefPubMed Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D (2009) Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos 37:74–81CrossRefPubMed
21.
Zurück zum Zitat Machlab S, Miquel M, Vergara M, Escoda MR, Casas M (2019) Apixaban-induced liver injury. Rec Esp Enferm Dig 111:161–163 Machlab S, Miquel M, Vergara M, Escoda MR, Casas M (2019) Apixaban-induced liver injury. Rec Esp Enferm Dig 111:161–163
22.
Zurück zum Zitat Pasin F, Esteban MDP, Testa S (2019) Apixaban-induced fatal liver injury with a cholestatic pattern: a case report and brief review of the literature. Eur J Intern Med 70:e17–e18CrossRefPubMed Pasin F, Esteban MDP, Testa S (2019) Apixaban-induced fatal liver injury with a cholestatic pattern: a case report and brief review of the literature. Eur J Intern Med 70:e17–e18CrossRefPubMed
23.
Zurück zum Zitat Byon W, Garonzik S, Boyd RA, Frost CE (2019) Apixaban: a clinical pharmacokintetic and pharmacodynamics review. Clin Pharmacokinet 58:1265–1279CrossRefPubMedPubMedCentral Byon W, Garonzik S, Boyd RA, Frost CE (2019) Apixaban: a clinical pharmacokintetic and pharmacodynamics review. Clin Pharmacokinet 58:1265–1279CrossRefPubMedPubMedCentral
Metadaten
Titel
Complete investigations (autopsy, toxicology, and histology) in a death due to apixaban overdose
verfasst von
Pascal Kintz
Charlotte Allain
Laetitia Oertel
Emilie Feisthauer
Alice Ameline
Jean-Sébastien Raul
Publikationsdatum
05.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 6/2023
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-023-03073-3

Neu im Fachgebiet Rechtsmedizin

Overview of a comparative analysis of microsatellite instability and standard mismatch repair protein-deficiency tests in a large cancer cohort

  • Hauptreferate: Hauptprogramm der DGP

A retrospective analysis was carried out based on a large cancer patient cohort of our institute ( n  = 1306; collected from 2018 to 2023). dMMR was tested by four IHC reactions (MLH1 and PMS2 or MSH2 and MSH 6). Further, parallel pentaplex …

Molekulare Testung bei mesenchymalen Neoplasien: Was, wann und wie testen?

Mit dem weit verbreiteten Einsatz diverser molekularer Methoden in der histopathologischen Routinediagnostik hat die Tumorklassifikation in den letzten beiden Jahrzehnten signifikante Fortschritte gemacht. Dabei wurden zum einen zahlreiche …

Reconstructing 3D histological structures using machine learning (artificial intelligence) algorithms

  • Hauptreferate: Hauptprogramm der DGP

Artificial intelligence (AI) has recently been applied to pathological and medical image analysis with high sensitivity and specificity [ 1 , 2 ], aiding in various dental diagnostic techniques. The use of AI in image annotation has enhanced the …

Key considerations when implementing new diagnostic technologies in routine practice

  • Hauptreferate: Arbeitsgemeinschaften der DGP

This review explores several key considerations that are critical for implementing new diagnostic technologies into routine practice. These elements will provide a comprehensive guide for navigating the complexities of integrating cutting-edge …